|
Volumn 24, Issue 4, 2001, Pages 359-363
|
Safety and availability of doxazosin in treating hypertensive patients with chronic renal failure
a a a a a a a a a a a a a a |
Author keywords
Chronic renal failure; Doxazosin; Hypertension; Proteinuria; Renal protection
|
Indexed keywords
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
ANTIHYPERTENSIVE AGENT;
CREATININE;
DIURETIC AGENT;
DOXAZOSIN;
FUROSEMIDE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
TRIACYLGLYCEROL;
ADULT;
AGED;
ARTICLE;
BLOOD PRESSURE MEASUREMENT;
CHOLESTEROL BLOOD LEVEL;
CHRONIC KIDNEY FAILURE;
CLINICAL ARTICLE;
COMORBIDITY;
CONTROLLED STUDY;
CORRELATION FUNCTION;
CREATININE BLOOD LEVEL;
DIASTOLIC BLOOD PRESSURE;
DISEASE COURSE;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG SAFETY;
FEMALE;
GLOMERULUS FILTRATION;
HUMAN;
HYPERTENSION;
LIPID ANALYSIS;
MALE;
PROTEINURIA;
RENAL SYSTEM PARAMETERS;
SIDE EFFECT;
SYSTOLIC BLOOD PRESSURE;
TITRIMETRY;
TRIACYLGLYCEROL BLOOD LEVEL;
UREA NITROGEN BLOOD LEVEL;
ADRENERGIC ALPHA-ANTAGONISTS;
ADULT;
AGED;
ANTIHYPERTENSIVE AGENTS;
BIOLOGICAL AVAILABILITY;
BLOOD PRESSURE;
DOXAZOSIN;
FEMALE;
HUMANS;
HYPERTENSION;
KIDNEY;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
SAFETY;
|
EID: 0034867541
PISSN: 09169636
EISSN: None
Source Type: Journal
DOI: 10.1291/hypres.24.359 Document Type: Article |
Times cited : (20)
|
References (10)
|